MELD Calculator (Model for End-Stage Liver Disease)

Enter bilirubin, INR, creatinine, sodium, and recent dialysis status to calculate the MELD and sodium-adjusted MELD-Na scores used to gauge liver disease severity and transplant priority.

Quick Facts

Base formula
3.78*ln(bilirubin) + 11.2*ln(INR) + 9.57*ln(creatinine) + 6.43
Lab values under 1.0 are rounded up to 1.0 before the logarithm is taken.
Sodium adjustment
MELD + 1.32*(137-Na) - 0.033*MELD*(137-Na)
Applied only when the base MELD score is above 11; sodium is bounded to 125-137 mmol/L.
Score range
6 to 40 points
Used by UNOS/OPTN to help prioritize deceased-donor liver transplant candidates.

Your Results

Calculated
MELD-Na score
-
Sodium-adjusted (6-40)
Original MELD score
-
Before sodium adjustment (6-40)
Est. 3-month mortality
-
Original MELD validation band
Severity category
-
Based on MELD-Na

Ready

Enter bilirubin, INR, creatinine, and sodium, then calculate the MELD-Na score.

Frequently Asked Questions

What is the MELD score?
The Model for End-Stage Liver Disease (MELD) score is a lab-based measure of liver disease severity calculated from serum bilirubin, INR, and creatinine. Originally developed to predict short-term mortality after a TIPS procedure, it was adopted in 2002 by UNOS to prioritize candidates on the U.S. liver transplant waiting list. Higher scores indicate more severe liver dysfunction and higher predicted short-term mortality without transplant.
How is the MELD-Na score calculated?
The base MELD score is 3.78 x ln(bilirubin) + 11.2 x ln(INR) + 9.57 x ln(creatinine) + 6.43, with any lab value below 1.0 rounded up to 1.0 and creatinine capped at 4.0 mg/dL. When that score is above 11, sodium is factored in: MELD-Na = MELD + 1.32 x (137 - Na) - [0.033 x MELD x (137 - Na)], with sodium bounded between 125 and 137 mmol/L. The final score is rounded and bounded between 6 and 40.
How does the MELD-Na score affect transplant priority?
Since January 2016, the United Network for Organ Sharing (UNOS) has used the sodium-adjusted MELD-Na score, rather than the original MELD score, to rank most adult candidates on the U.S. deceased-donor liver waiting list. Candidates with higher MELD-Na scores generally receive higher priority, since the score correlates with short-term mortality risk. Actual allocation also depends on blood type, geography, and exception points, and is ultimately determined by the transplant team and UNOS policy, not by this calculator.

About the MELD Calculator (Model for End-Stage Liver Disease)

The Model for End-Stage Liver Disease (MELD) score is a laboratory-based measure of liver disease severity, built from three routine blood tests: serum bilirubin, INR (international normalized ratio), and serum creatinine. It was originally developed to predict mortality after a transjugular intrahepatic portosystemic shunt (TIPS) procedure, then adopted in 2002 to rank adult candidates on the U.S. liver transplant waiting list. Since January 2016, the sodium-adjusted variant, MELD-Na, has been the primary score used for that ranking.

How the score is calculated

The base score is MELD = 3.78 x ln(bilirubin) + 11.2 x ln(INR) + 9.57 x ln(creatinine) + 6.43. Any bilirubin, INR, or creatinine value below 1.0 is rounded up to 1.0 before the logarithm is taken, and creatinine is capped at 4.0 mg/dL (and set to exactly 4.0 if the patient had two or more dialysis sessions, or 24 hours of continuous veno-venous hemodialysis, in the past week). When the resulting score is above 11, sodium is factored in: MELD-Na = MELD + 1.32 x (137 - Na) - [0.033 x MELD x (137 - Na)], with sodium bounded between 125 and 137 mmol/L beforehand. Both the final MELD and MELD-Na values are rounded to the nearest whole number and bounded between 6 and 40.

Interpreting the result

Higher scores indicate more severe liver dysfunction and a higher published rate of short-term mortality. In the original validation cohort, three-month mortality rose from roughly 2% at scores under 10 to about 20% in the 20s, over 50% in the 30s, and above 70% at 40 or above. These bands describe a study population, not an individual patient, and are provided for context rather than as a personal prognosis.

When to consult a professional

This tool performs the standard MELD and MELD-Na arithmetic for education and record-keeping. It does not diagnose liver disease and does not determine actual waiting-list priority, which also depends on blood type, geography, exception points, and UNOS/OPTN policy. Any decision about liver disease management or transplant listing should be made with a hepatologist or transplant team.